Institutional Biosafety Committee Information

Research that involves recombinant DNA and/or biohazardous materials should be registered with the Institutional Biosafety Committee (IBC). The IBC is responsible for ensuring compliance with NIH Guidelines and assigns appropriate biosafety level determinations for research on campus.

All faculty performing research involving recombinant DNA and/or biohazardous materials should complete a New IBC application within Cayuse Hazard Safety. A new IBC protocol must be submitted every 3 years and updated annually as needed. To access Cayuse, log in through PipelineMT and scroll down to the Employee Resources block on the Home Page and choose Cayuse. If you have any issues with Cayuse, please contact the Office of Research and Sponsored Programs.

The IBC will send the faculty member a written notice of approval for their research, along with a termination date for the approval. Faculty must submit any changes or renewals annually using the change/renewal form below.

The NIH Guidelines and Lentiviral Vector Containment Guidelines are below for more information.

NIH Guidelines April 2019

Lentiviral Vector Containment Guidelines

TwitterFacebook